TELA Bio, Inc. (NASDAQ: TELA) reported Q1 EPS of ($0.63), $0.09 worse than the analyst estimate of ($0.54). Revenue for the quarter came in at $11.9 million versus the consensus estimate of $11.91 million.

For earnings history and earnings-related data on TELA Bio, Inc. (TELA) click here.